Mr Amit Duggal, Assistant Commissioner Drugs, FDA Punjab
Chandigarh Pharma Summit 2025 | 6th August 2025 | Taj Chandigarh
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Kantar study maps India’s health and wellness search trends for 2024
New report analyses 15 wellness categories to reveal changing consumer focus areas based on Google search patterns
Celcius Logistics launches Celcius+ to strengthen pharma cold supply chain in India
₹50 crore investment to build dedicated pharma fleet, infrastructure, and compliance-driven logistics solutions
Bionova Scientific launches Texas pDNA facility to expand cell and gene therapy capabilities
The Woodlands site to support research-grade and CGMP plasmid DNA production for advanced therapeutics by late 2025
The Saffron book: An orange book of India
Milind Sathe highlights the need for a publicly accessible Indian equivalent of the US FDA’s Orange Book, proposing a Saffron Book…
Lupin announces licensing deal for Ranibizumab biosimilar
Lupin will manufacture and file regulatory submissions, while Sandoz will commercialise the biosimilar across select global…
T-cell engagers to drive immuno-oncology next growth wave: GlobalData
Bispecific T-cell engagers forecast to expand from 10% to 35% of the global immuno-oncology market by 2031 as immune checkpoint…
U.S. Tariffs on India’s pharma: Who pays, what’s at risk
The structural answer to tariff risk is not endless cost-cutting; it is moving up the value chain
Pfizer launches Pneumococcal Conjugate Vaccine for adults in India
Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes including both invasive and…
Eyestem Research raises $10 million to advance Eyecyte-RPE cell therapy for dry AMD
Funding to support Phase 2 clinical trial in India and preparations for US FDA Investigational New Drug application